ImmunoACT
Juber Pendhari is a scientist at ImmunoACT since January 2022, focusing on research and manufacturing. Concurrently, Juber serves as a Junior Research Fellow at the Indian Institute of Technology, Bombay, beginning in August 2021. Prior experience includes a role as a research student at Bombay College of Pharmacy from August 2018 to October 2021. Juber Pendhari holds an M. Pharm in Pharmaceutics and Drug Design from Bombay College of Pharmacy (2018-2020) and a B. Pharm in Pharmacy from Bharati Vidyapeeth College of Pharmacy, Kolhapur (2014-2018).
ImmunoACT
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer in the development of the country's first indigenous Cell & Gene Therapy. With a rapidly expanding pipeline beginning with blood cancers, our mission is to provide affordable access to novel autologous CAR-T cell therapies.